Nebulized Bupivacaine Analgesia for Cleft Palate Repair
ConditionCleft Palate
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age1-7
SponsorAssiut University
About this trial
In this study we introduce a potent local anesthetic; bupivacaine 0.5% in 0.5 mg/kg dose by nebulization as a preemptive analgesia to compare efficacy and safety in children with cleft palate repair.
Eligibility criteria
Qualifiers
Children (age 1-7 years) of American Society of Anaesthesiologists physical status (ASA) I-II
Elective cleft palate repair ± cleft lip surgery under general anesthesia .
Disqualifiers
Coronary artery disease
Hypertension
Developmental delay
Allergy to study drug
Trial design
Treatments tested in this trial
- Bupivacaine Hydrochloride
- 0.9% saline
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov